Application of DMX-5804 in preparation of medicine for inhibiting gemmation of aurelia aurita

By using DMX-5804 compounds in the sea moon jellyfish hydrodynas, the budding rate and germination number have been significantly reduced, and the problem of controlling the outbreak of sea moon jellyfish has been solved, providing effective prevention and control measures for the marine ecological environment and human economic activities.

CN119015287AActive Publication Date: 2024-11-26THE NAVAL MEDICAL UNIV OF PLA

Patent Information

Application Number
CN202411039107.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-26
Estimated Expiration
2044-07-31

AI Technical Summary

Technical Problem

The prior art is difficult to effectively inhibit the budding and reproduction of the sea moon jellyfish hydrate body, resulting in the difficulty in controlling the outbreak of sea moon jellyfish, affecting the marine ecological environment and human coastal economic activities.

Method used

Using the DMX-5804 compound, placing the DMX-5804 solution at a concentration of 1-10 μM in artificial seawater and cultured the germination rate and germination number significantly reduced.

Benefits of technology

Experimental verification showed that the number of germinations in the DMX-5804 treatment group was significantly lower than that in the control group within 14 days, providing a theoretical basis for the prevention and control of the outbreak of sea moon jellyfish, and DMX-5804 did not affect the living status of germinations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015287A_ABST
    Figure CN119015287A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of prevention and control of jellyfish, and discloses application of DMX-5804 in preparation of a medicine for inhibiting gemmation of jellyfish. By inhibiting germination and reproduction of A.coerulea hydranth, the eruption of aurelia can be prevented and treated, and adverse effects on the marine ecological environment and human coastal economic activities are reduced. Experiments prove that 1 [mu] M of DMX-5804 can reduce the budding number of hydranths under the condition that the living state of A.coerulea hydranths is not influenced; it is prompted that the compound DMX-5804 at the concentration can inhibit asexual proliferation of aurelia under the condition that toxicity is not generated. The invention provides a new theory and method for controlling the number of jellyfishes, preventing and treating the outbreak of aurelia jellyfishes and researching a biological conservative cell proliferation strategy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of jellyfish prevention and control, and more specifically, to the application of DMX-5804 in the preparation of a medicine for inhibiting the budding reproduction of moon jellyfish. Background Art

[0002] Jellyfish outbreaks are considered to be a very serious ecological disaster and have attracted widespread social attention in recent years. Among them, the number of moon jellyfish (Aurelia coerulea) has shown an increasing trend year by year along the coasts of the Yellow Sea and Bohai Sea in my country, and has become one of the main jellyfish populations that cause disasters in my country. The moon jellyfish (Aurelia coerulea) belongs to the phylum Cnidaria and has a complex life cycle consisting of several stages, including alternating generations of medusae that live in the planktonic life and polyps that live in the sessile life, which belong to sexual reproduction and asexual reproduction respectively. The polyps of the moon jellyfish are the asexual generation of the moon jellyfish, which mainly expand their populations through asexual reproduction. Its asexual reproduction is divided into two different directions: budding reproduction and metamorphosis. On the one hand, budding is used for self-replication to increase the population of the polyp stage, providing a quantitative basis for the outbreak of the moon jellyfish; on the other hand, metamorphosis is used to release the transverse body and the disc-shaped body, and finally a large number of adult jellyfish are produced, causing the outbreak of the moon jellyfish. By inhibiting the budding reproduction of A. coerulea polyps, the outbreak of moon jellyfish can be prevented from the early polyp stage, reducing the adverse effects on the marine ecological environment and human coastal economic activities.

[0003] Previously, due to the limitations of research methods and the lack of genetic information on the polyps of moon jellyfish, research on the control of the number of moon jellyfish has been limited to the effects of environmental factors such as temperature, bait, and salinity on the reproduction of jellyfish and their polyps. In recent years, some studies have focused on the molecular mechanisms of metamorphosis of jellyfish polyps and their intervention. However, inhibiting metamorphosis can only reduce the number of adult jellyfish to a certain extent. The population reserve in the benthic polyp stage before metamorphosis is the root problem that needs to be solved to control jellyfish outbreaks. However, there is currently a lack of methods to intervene and regulate the budding and proliferation of jellyfish polyps through key inhibitors. Summary of the invention

[0004] In order to overcome the deficiencies of the prior art, the present invention aims to provide an application of DMX-5804 in inhibiting the budding reproduction of moon jellyfish.

[0005] The purpose of the present invention is achieved through the following technical solutions:

[0006] The present invention firstly provides application of DMX-5804 in inhibiting budding reproduction of moon jellyfish.

[0007] The present invention verifies through experiments that, after incubation for 14 days in artificial seawater reagents with concentrations of 1 μM and 10 μM DMX-5804, the DMX-5804 treatment group can significantly reduce the polyp budding rate and the number of buds at the same time, thereby reducing the number of jellyfish.

[0008] Therefore, the present invention also provides the use of DMX-5804 in the preparation of a drug for inhibiting the budding reproduction of the moon jellyfish.

[0009] The present invention also provides the use of DMX-5804 in preparing a functional product for preventing and controlling the outbreak of moon jellyfish.

[0010] Therefore, preferably, in the above application, the concentration of DMX-5804 is 1-10 μM.

[0011] In the above applications, DMX-5804 has the following functions:

[0012] (1) reducing the budding rate of the polyps of the moon jellyfish, and / or

[0013] (2) reducing the number of budding polyps of the moon jellyfish, and / or

[0014] Therefore, the present invention also provides a method for inhibiting the budding reproduction of moon jellyfish, comprising the following steps:

[0015] A. Preparation of inhibitor seawater solution: Prepare a DMX-5804 solution with a concentration of 1-10 μM using seawater;

[0016] B. Place the moon jellyfish polyp in the DMX-5804 solution and culture for 2-14 days.

[0017] Compared with the prior art, the present invention has the following beneficial effects:

[0018] The present invention found that the compound DMX-5804 can inhibit the budding rate of the budding reproduction of the jellyfish polyp. Through experiments, it was verified that incubating the jellyfish polyp with 1μM and 10μM DMX-5804 can reduce the number of buds of the jellyfish polyp. The results showed that from the second day to the fourteenth day of the experiment, the number of buds in the DMX-5804 treatment group was less than that in the control group, which provides a theoretical basis for the prevention and control of jellyfish outbreaks. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 The figure shows the changes in the number of buds of the polyps in the 1μM DMX-5804 treatment group and the control group during the experimental period (left) and the 10μM DMX-5804 treatment group and the control group (right);

[0020] Figure 2The figure shows the changes in the number of buds of the polyps in the 1μM Homosalate treatment group and its control group (left) and the 10μM Homosalate treatment group and its control group (right) during the experimental period.

[0021] Figure 3 This is a microscopic picture of the budding and proliferation process of a representative moon jellyfish polyp in the experiment. DETAILED DESCRIPTION

[0022] In order to better illustrate the purpose, technical scheme and advantages of the present invention, the present invention will be further described below in conjunction with specific drawings and embodiments. In the embodiments, the experimental methods used are conventional methods unless otherwise specified, and the materials, reagents, etc. used are all commercially available unless otherwise specified.

[0023] 1. Experimental Materials

[0024] Experimental animals: Polyps of the moon jellyfish (cultivated by mECC Golden Club), reagents: DMX-5804 (2 mg, Taoshu Biological T5483), DMSO (Boguang Biological), and DMX-5804 incubation solution was prepared using artificial seawater at 28‰-32‰.

[0025] Instruments: constant temperature incubator (Bangsi Instrument Technology Co., Ltd.), continuous zoom stereo microscope (Chongqing Aote Optical Instrument Co., Ltd.), pipettes (eppendorf) (10μl, 100μl, 200μl, 1000μl), electronic balance AL204 (precision) (Mettler-Toledo Instrument Co., Ltd.), seawater salinity meter (AS-ST10 Aicevoos Official Flagship Store).

[0026] 2. Experimental Methods

[0027] 1. Prepare sterile artificial seawater: prepare artificial seawater with a salinity of 28‰-32‰, sterilize it at high temperature, and then adjust the salinity again.

[0028] 2. Experimental Animal Preparation

[0029] Two weeks in advance, select the well-growing polyps of the moon jellyfish from the hydra breeding tank and inoculate them into a new 12-well plate. After one week of inoculation, observe the inoculation situation and feed them appropriately (to ensure the health of the polyps). Set up two groups, the experimental group and the control group, each with a 12-well plate, 3 polyps in each well, a total of 36 polyps; after they are fully attached, start feeding regularly, feeding once every 4 days, and replace the seawater 2 hours after feeding.

[0030] 3. Prepare DMX-5804 seawater solution

[0031] (1) Preparation of 10 mM DMX-5804 stock solution: Dissolve 1 mg DMX-5804 in 276.7017 μl DMSO to prepare a 10 mM DMX-5804 stock solution.

[0032] (2) Preparation of 10 μM DMX-5804 seawater solution: 30 μl of 10 mM DMX-5804 stock solution was added to 29.97 ml of artificial seawater to obtain a total volume of 30 ml of 10 μM DMX-5804 seawater solution.

[0033] (3) Preparation of 1 μM DMX-5804 seawater solution in the experimental group: 3 ml of 10 μM DMX-5804 seawater solution was added to 27 ml of artificial seawater to obtain a total volume of 30 ml of 1 μM DMX-5804 seawater solution.

[0034] 4. Prepare Homosalate seawater solution

[0035] (1) Preparation of 100 mM Homosalate stock solution: Dissolve 1 mg Homosalate in 381.1847 μl DMSO to prepare 10 mM Homosalate stock solution.

[0036] (2) Preparation of 10 μM Homosalate seawater solution: 30 μl of 10 mM Homosalate solution was added to 29.97 ml of artificial seawater to obtain a total volume of 30 ml of 100 μM Homosalate seawater solution.

[0037] (3) Preparation of 1 μM Homosalate seawater solution for the experimental group: 3 ml of 10 μM Homosalate solution was added to 27 ml of artificial seawater to obtain a total volume of 30 ml of 1 μM Homosalate seawater solution.

[0038] 5. Prepare the seawater solution for the control group

[0039] (1) Preparation of 1 μM inhibitor control group 0.01% DMSO seawater solution: 3 μl DMSO was added to 29.997 ml artificial seawater to obtain a total volume of 30 ml 0.01% DMSO seawater solution.

[0040] (2) Preparation of 10 μM inhibitor control group 0.1% DMSO seawater solution: 30 μl DMSO was added to 29.97 ml artificial seawater to obtain a total volume of 30 ml 0.1% DMSO seawater solution.

[0041] 6. Incubate the polyps with inhibitor seawater solution

[0042] The artificial seawater in the 12-well plate of the polyps in the DMX-5804 treatment group was completely replaced with 1 μM DMX-5804 seawater solution and 10 μM DMX-5804 seawater solution, respectively; the artificial seawater in the 12-well plate of the polyps in the Homosalate treatment group was completely replaced with 1 μM Homosalate seawater solution and 10 μM Homosalate seawater solution, respectively; the artificial seawater in the 12-well plate of the polyps in the control group was completely replaced with the corresponding 0.01% DMSO seawater solution and 0.1% DMSO seawater solution, and cultured in a constant temperature incubator at 20°C, and fed and water was changed every 4 days.

[0043] 7. Germination observation

[0044] Mark the groups and time on a 12-well plate, add the corresponding solution to each group at the same time (2 ml for each well), and culture in a 20°C constant temperature incubator. Observe every 24 hours from the 1st to the 7th day, and take photos with a stereo microscope for record. Observe whether the polyps have sprouted, the time of sprouting, and the number of sprouts, and calculate the budding rate and other indicators.

[0045] 3. Results Analysis

[0046] The experiment found that during the experimental period, the number of polyp buds in the 1μM DMX-5804 treatment group and the 10μM DMX-5804 treatment group was significantly lower than that in the control group ( Figure 1 ), the tentacles of the polyp were well extended during the experiment ( Figure 3 ), and the feeding was normal, indicating that DMX-5804 had no effect on the life state of the polyps of the moon jellyfish. This suggests that the compound DMX-5804 at this concentration can inhibit the asexual proliferation of the moon jellyfish without causing toxicity. On the contrary, the number of polyps budding in the 1μM and 10μM Momosalate treatment groups showed a change of first decreasing and then increasing, and finally both were higher than the number of budding in the control group ( Figure 2 ), indicating that, unlike the effect of the inhibitor on polyp metamorphosis, Homosalate has no inhibitory effect on the budding reproduction of the polyp of the moon jellyfish.

[0047] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. Application of DMX-5804 in inhibiting budding reproduction of moon jellyfish.

2. Application of DMX-5804 in the preparation of drugs for inhibiting the budding reproduction of moon jellyfish.

3. The use according to claim 1 or 2, characterized in that: The concentration of DMX-5804 was 1-10 μM.

4. A method for inhibiting the budding reproduction of moon jellyfish, characterized in that: The following steps are involved: A. Preparation of inhibitor seawater solution: Prepare a DMX-5804 solution with a concentration of 1-10 μM using seawater; B. Place the moon jellyfish polyp in the DMX-5804 solution and culture for 2-14 days.

Citation Information

Patent Citations

  • Map4k4 inhibitors

    CN112585147A

  • Application of Homosalate in prevention and control of jellyfish outbreak

    CN116636530A

  • Application of alpha-Lindenic acid in inhibiting metamorphosis development process of aurelia

    CN117426383A

Cited By

  • Bacillus paramycosis capable of inhibiting asexual reproduction of disaster jellyfish scyphistoma and application of bacillus paramycosis

    CN118546822A

  • A strain of Bacillus paramycoides capable of inhibiting asexual reproduction of jellyfish polyps and its application

    CN118546822B